Advances in relapse risk factors of anti-N-methyl-D-aspartate receptor encephalitis
10.3760/cma.j.cn113694-20220519-00403
- VernacularTitle:抗N-甲基-D-天冬氨酸受体脑炎复发危险因素的研究进展
- Author:
Fang ZHANG
1
;
Yuchen LI
;
Huijun SHEN
;
Yingshi GUO
;
Jing WANG
;
Jie WANG
Author Information
1. 山西医科大学研究生院,太原 030000
- Keywords:
Encephalitis;
Receptors, N-methyl-D-aspartate;
Recurrence;
Risk factors
- From:
Chinese Journal of Neurology
2023;56(1):106-110
- CountryChina
- Language:Chinese
-
Abstract:
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune encephalitis mediated by anti-NMDAR antibody. Current studies have found that most patients with anti-NMDAR encephalitis have a good prognosis after immunotherapy and tumor therapy, but there are still 4.5%-36.4% patients with relapse. It is important to identify the risk factors for the prevention of relapse. This article aims to review the relapse risk factors of NMDAR encephalitis in order to provide help for the prevention of relapse.